Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for Insomnia in Cirrhosis
NCT03091738Phase 4Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Feb 2017
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ramelteon in Insomnia, sponsored by Virginia Commonwealth University. Primary endpoint: Sleep Quality Evaluation at 14 days. Started Feb 2017; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03091738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091738.